640
Views
51
CrossRef citations to date
0
Altmetric
Original

The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: A case report

, , , &
Pages 485-495 | Published online: 07 Jul 2009

References

  • Aldhous M. E., Arendt J. Radioimmunoassay for 6‐sulphatoxymelatonin in urine using an iodinated tracer. Ann. Clin. Biochem. 1988; 25(Pt3)298–303
  • Ancoli‐Israel S., Cole R., Alessi C., Chambers M., Moorcroft W., Pollak C. P. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26: 342–392
  • Arendt J. Melatonin assays in body fluids. J. Neural Transm. Suppl. 1978; 265–278
  • Arendt J., Skene D. J. Melatonin as a chronobiotic. Sleep Med. Rev. 2005; 9: 25–39
  • Arendt J., Bojkowski C., Franey C., Wright J., Marks V. Immunoassay of 6‐hydroxymelatonin sulfate in human plasma and urine: Abolition of the urinary 24‐hour rhythm with atenolol. J. Clin. Endocrinol. Metab. 1985; 60: 1166–1173
  • Ayalon L., Hermesh H., Dagan Y. Case study of circadian rhythm sleep disorder following haloperidol treatment: Reversal by risperidone and melatonin. Chronobiol. Int. 2002; 19: 947–959
  • Benloucif S., Guico M. J., Reid K. J., Wolfe L. F., L'Hermite‐Baleriaux M., Zee P. C. Stability of melatonin and temperature as circadian phase markers and their relation to sleep times in humans. J. Biol. Rhythms 2005; 20: 178–188
  • Boivin D. B., Czeisler C. A. Resetting of circadian melatonin and cortisol rhythms in humans by ordinary room light. Neuroreport 1998; 9: 779–782
  • Boivin D. B., Duffy J. F., Kronauer R. E., Czeisler C. A. Dose‐response relationships for resetting of human circadian clock by light. Nature 1996; 379: 540–542
  • Cagnacci A., Krauchi K., Wirz‐Justice A., Volpe A. Homeostatic versus circadian effects of melatonin on core body temperature in humans. J. Biol. Rhythms 1997; 12: 509–517
  • Crowley S. J., Lee C., Tseng C. Y., Fogg L. F., Eastman C. I. Complete or partial circadian re‐entrainment improves performance, alertness, and mood during night‐shift work. Sleep 2004; 27: 1077–1087
  • Dijk D. J., von Schantz M. Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators. J. Biol. Rhythms 2005; 20: 279–290
  • Eastman C. I., Young M. A., Fogg L. F., Liu L., Meaden P. M. Bright light treatment of winter depression: A placebo‐controlled trial. Arch. Gen. Psichiatr. 1998; 55: 883–889
  • Haffmans P. M.J., Oolders J. M., Hoencamp E., Arends J. B.A.M. The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients: Results of a double‐blind, randomised pilot trial. Eur. Neuropsychopharmacol. 2001; 11(Suppl. 3)S260
  • Haug H. J., Wirz‐Justice A., Rossler W. Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patients. Acta Psychiatr. Scand. Suppl. 2000; 91–95
  • Hinze‐Selch D., Mullington J., Orth A., Lauer C. J., Pollmacher T. Effects of clozapine on sleep: A longitudinal study. Biol. Psych. 1997; 42: 260–266
  • Khalsa S. B., Jewett M. E., Cajochen C., Czeisler C. A. A phase response curve to single bright light pulses in human subjects. J. Physiol. 2003; 549: 945–952
  • Krauchi K., Cajochen C., Wirz‐Justice A. A relationship between heat loss and sleepiness: Effects of postural change and melatonin administration. J. Appl. Physiol. 1997; 83: 134–139
  • Kripke D. F. Light treatment for nonseasonal depression: Speed, efficacy, and combined treatment. J. Affect. Disord. 1998; 49: 109–117
  • Lewy A. J., Sack R. L. The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int. 1989; 6: 93–102
  • Lewy A. J., Bauer V. K., Cutler N. L., Sack R. L., Ahmed S., Thomas K. H., Blood M. L., Jackson J. M. Morning vs. evening light treatment of patients with winter depression. Arch. Gen. Psychiatr. 1998; 55: 890–896
  • Mann K., Rossbach W., Muller M. J., Muller‐Siecheneder F., Pott T., Linde I., Dittmann R. W., Hiemke C. Nocturnal hormone profiles in patients with schizophrenic treated with olanzapine. Psychoneuroendocrinology 2005; xx: 1–9
  • Martin J., Jeste D. V., Caliguiri M. P., Patterson T., Heaton R., Ancoli‐Israel S. Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenic patients. Schizophr. Res. 2001; 47: 77–86
  • Mills J. N., Morgan R., Minors D. S., Waterhouse J. M. The free‐running circadian rhythms of two schizophrenics. Chronobiologia 1977; 4: 353–360
  • Rodenbeck A., Huether G., Ruther E., Hajak G. Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep‐wake rhythm disorders. J. Pineal Res. 1998; 25: 201–210
  • Roenneberg T., Wirz‐Justice A., Merrow M. Life between clocks: Daily temporal patterns of human chronotypes. J. Biol. Rhythms 2003; 18: 80–90
  • Rosenthal N. E., Sack D. A., Gillin J. C., Lewy A. J., Goodwin F. K., Davenport Y., Mueller P. S., Newsome D. A., Wehr T. A. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psych. 1984; 41: 72–80
  • Sack R. L., Lewy A. J., Hughes R. J. Use of melatonin for sleep and circadian rhythm disorders. Ann. Med. 1998; 30: 115–121
  • Salin‐Pascual R. J., Herrera‐Estrella M., Galicia‐Polo L., Laurrabaquio M. R. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol. Psych. 1999; 46: 141–143
  • Shibui K., Uchiyama M., Okawa M. Melatonin rhythms in delayed sleep phase syndrome. J. Biol. Rhythms 1999; 14: 72–76
  • Skene D. J., Lockley S. W., Arendt J. Melatonin in circadian sleep disorders in the blind. Biol. Signals Recept. 1999a; 8: 90–95
  • Skene D. J., Lockley S. W., Arendt J. Use of melatonin in the treatment of phase shift and sleep disorders. Adv. Exp. Med. Biol. 1999b; 467: 79–84
  • Terman J. S., Terman M. Photopic and scotopic light detection in patients with seasonal affective disorder and control subjects. Biol. Psych. 1999; 46: 1642–1648
  • Terman M., Terman J. S. Light therapy for seasonal and nonseasonal depression: Efficacy, protocol, safety, and side effects. CNS Spectr. 2005; 10: 647–663, quiz 672
  • Touitou Y., Portaluppi Y., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21: 161–170
  • Uchiyama M., Okawa M., Shibui K., Kim K., Tagaya H., Kudo Y., Kamei Y., Hayakawa T., Urata J., Takahashi K. Altered phase relation between sleep timing and core body temperature rhythm in delayed sleep phase syndrome and non‐24‐hour sleep‐wake syndrome in humans. Neurosci. Lett. 2000; 294: 101–104
  • Weitzman E. D., Czeisler C. A., Coleman R. M., Spielman A. J., Zimmerman J. C., Dement W., Richardson G., Pollak C. P. Delayed sleep phase syndrome. A chronobiological disorder with sleep‐onset insomnia. Arch. Gen. Psych. 1981; 38: 737–746
  • Wirz‐Justice A., Cajochen C., Nussbaum P. A schizophrenic patient with an arrhythmic circadian rest‐activity cycle. Psychiatry Res. 1997; 73: 83–90
  • Wirz‐Justice A., Werth E., Savaskan E., Knoblauch V., Gasio P. F., Muller‐Spahn F. Haloperidol disrupts, clozapine reinstates the circadian rest‐activity cycle in a patient with early‐onset Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2000; 14: 212–215
  • Wirz‐Justice A., Haug H. J., Cajochen C. Disturbed circadian rest‐activity cycles in schizophrenic patients: An effect of drugs?. Schizophr. Bull. 2001; 27: 497–502
  • Wright K. P., Jr., Gronfier C., Duffy J. F., Czeisler C. A. Intrinsic period and light intensity determine the phase relationship between melatonin and sleep in humans. J. Biol. Rhythms 2005; 20: 168–177
  • Wulff K., Siegmund R. Time pattern analysis of activity‐rest rhythms in families with infants using actigraphy. Awakening and Sleep‐wake Cycle Across Development (Advances in Concsiousness Research), P. Salzarulo, G. Ficca. John Benjamins, Amsterdam/Philadelphia 2002; 149–169
  • Zeitzer J. M., Dijk D. J., Kronauer R., Brown E., Czeisler C. Sensitivity of the human circadian pacemaker to nocturnal light: Melatonin phase resetting and suppression. J. Physiol. 2000; 526: 695–702

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.